|
1）Hecht SS. Tobacco smoke carcinogens and lung cancer. J Nat Cancer Inst. 1999; 91: 1194-210
|
|
|
|
2）West KA, Brognard J, Clark AS, et al. Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J Clin lnvest. 2003; 111: 81-90
|
|
|
|
|
|
3）Minegishi Y. Emphysema, fibrosis and carcinogenesis in the lung. J Clin Exp Med. 2012; 241: 906-11
|
|
|
|
|
|
4）Inoue K, Nakanishi Y, Kuwano K, et al. Idiopathic Pulmonary Fibrosis, Pulmonary Silicosis and Lung Cancer. Biotherapy. 2002; 16: 135-41
|
|
|
|
|
|
5）Fukuchi Y, Nishimura M, Ichinose M, et al. COPD in Japan: the Nippon COPD Epidemiology study. Respiratory. 2004; 9: 458-65
|
|
|
|
|
|
6）Akita H. Cancer development. COPD Frontier. 2003; 2: 325-9
|
|
|
|
|
7）Opitz B, van laak V, Eitel J, et al. Innate immune recognition in infectious and noninfectious diseases of the lung. Am J Respir Crit Care Med. 2010; 181: 1294-309
|
|
|
|
|
|
8）Kasahara Y, Tuder RM, Taraseviciene-Stewart L, et al. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Inves. 2000; 106: 1311-9
|
|
|
|
|
|
9）Kasahara Y, Tuder RM, Cool CD, et al. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor 2 in emphysema. Am J Respir Crit Care Med. 2001; 163: 737-44
|
|
|
|
|
|
10）Richens TR, Linderman DJ, Horstmann SA, et al. Cigarette smoke impairs clearance of apoptotic cells through oxidant-dependent activation of RhoA. Am J Respir Crit Care Med. 2009; 179: 1011-21
|
|
|
|
|
|
11）Mercado N, Thimlnulappa R, Thomas CM, et al. Decreased histone deacetylase 2 impairs Nrf2 activation by oxidative stress. Biochem Biophys Res Commun. 2011; 406: 292-8
|
|
|
|
|
|
12）Sekine S, Ichijo H. ROS in cancer. Exp Med. 2012; 30: 83-9
|
|
|
|
|
|
13）A Chatterjee, E Mambo, D Sidransky. Mitochondrial DNA mutations in human cancer. Oncogene. 2006; 25: 4663-74
|
|
|
|
|
|
14）Ishikawa K, Takenaga K, Akimoto M, et al. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science. 2008; 320: 661-4
|
|
|
|
|
|
15）Gottlieb E, Thomlinson IP. Mitochondrial tumour suppressors: a genetic and biochemical update. Nature Reviews. Cancer. 2005; 5: 857-66
|
|
|
|
|
|
16）Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol. 2004; 4: 181-9
|
|
|
|
|
|
17）Park HS, Jung HY, Park EY, et al. Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kappa B. J Immunol. 2004; 173: 3589-93
|
|
|
|
|
|
18）Kim YS, Morgan MJ, Choksi S, et al. TNF-induced activation of the Nox1 NADPH oxidase and its role in the induction of necrotic cell death. Mol Cell. 2007; 26: 675-87
|
|
|
|
|
|
19）Shinohara M, Shang WH, Kubodera M, et al. Nox1 redox signaling mediates oncogenic Ras-induced disruption of stress fibers and focal adhesions by downregulating Rho. J Bio Chem. 2007; 282: 17640-8
|
|
|
|
|
|
20）Komatsu D, Kato M, Nakayama J, et al. NADPH oxidase 1 plays a critical mediating role in oncogenic Ras-induced vascular endothelial growth factor expression. Oncogene. 2008; 27: 4724-32
|
|
|
|
|
|
21）Shinohara M, Adachi Y, Mitsushita J, et al. Reactive oxygen generated by NADPH oxidase 1 (Nox1) contributes to cell invasion by regulating matrix metalloprotease-9 production and cell migration. J Biol Chem. 2010; 285: 4481-8
|
|
|
|
|
|
22）Matsuzawa A, Saegusa K, Noguchi T, et al. ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. Nat Immunol. 2005; 6: 587-92
|
|
|
|
|
|
23）Nishitoh H, Saitoh M, Mochida Y, et al. ASK1 is essential for JNK/SAPK activation by TRAF2. Mol Cell. 1998; 2: 389-95
|
|
|
|
|
|
24）Takeda K, Shimozono R, Noguchi T, et al. Apoptosis signal-regulating kinase (ASK) 2 functions as a mitogen-activated protein kinase kinase kinase in a heteromeric complex with ASK1. J Biol Chem. 2007; 282: 7522-31
|
|
|
|
|
|
25）Serrano M, Lin AW, McCurrach ME, et al. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 1997; 88: 593-602
|
|
|
|
|
|
26）Odier F, Campisi J. Four faces of cellular senescence. J Cell Bio. 2011; 192: 547-56
|
|
|
|
|
|
27）Yang G, Rosen DG, Zhang Z, et al. The chemokine growth-regulated oncogene l (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis. Proc Nat Acad Sci U S A. 2006; 103: 16472-7
|
|
|
|
|
|
28）Alspach E, Flanagan KC, Luo X, et al. p38MAPK plays a crucial role in stromal-mediated tumorigenesis. Cancer Discov. 2014; 4: 716-29
|
|
|
|
|
|
29）Yoshimoto S, Loo TM, Atarashi K, et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature. 2013; 499: 97-101
|
|
|
|
|
|
30）Azuma A. Pirfenidone treatment of idiopathic pulmonary fibrosis. Ther Adv Respir Dis. 2012; 6: 107-14
|
|
|
|
|
|
31）Richeldi L, Costabel U, Selman M, et al. Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. N Eng J Med. 2011; 365: 1079-87
|
|
|
|
|